Morning Overview on MSN

The FDA approved a lower-dose contrast agent to cut patients’ exposure during MRI scans

Patients who need repeated MRI scans with contrast dye could soon receive a fraction of the gadolinium they currently get.
Neurology Advisor

FDA Approves Lower-Dose Gadolinium Contrast Agent Ambelvist

The FDA has approved Bayer’s Ambelvist (gadoquatrane), the lowest-dose macrocyclic GBCA for adult and pediatric contrast-enhanced CNS and body MRI exams.
Case Western Reserve University

MRI Contrast Agents Accumulate in the Brain

The International Society for Magnetic Resonance in Medicine (ISMRM) has provided new guidance in the use of contrast agents during MRI scans. Emerging research suggests gadolinium-based contrast ...
Medscape

Gadolinium-Based Contrast Agents and Brain Safety: Signal vs Noise

Gadolinium-based contrast agents (GBCAs) used in MRI and angiography contain a chelated form of the toxic heavy metal that was assumed to clear the body shortly after intravenous administration. [1] ...
Healio

FDA approves Ambelvist MRI contrast agent with lower dose of gadolinium

The FDA has approved Ambelvist, a macrocyclic gadolinium-based option for contrast-enhanced MRI, now the lowest ...